대한한방부인과학회지 (The Journal of Korean Obstetrics and Gynecology)

  • 제33권2호
  • /
  • Pages.13-28
  • /
  • 2020
  • /
  • 1229-4292(pISSN)
  • /
  • 2508-3619(eISSN)
대한한방부인과학회 (The Society of Korean Medicine Obstetrics and Gynecology)
권호 표지
DOI QR코드

DOI QR Code

자궁근종의 한약치료에 대한 최신 임상 연구 동향 - CNKI 검색을 중심으로

Research Trends of Herbal Medicine Treatment for Uterine Leiomyoma - Research using CNKI

  • 최유진 (동신대학교 한의과대학 한방부인과교실) ;
  • 김보리 (동신대학교 한의과대학 한방부인과교실) ;
  • 조성희 (동신대학교 한의과대학 한방부인과교실) ;
  • 양승정 (동신대학교 한의과대학 한방부인과교실)
  • Choi, Yu-Jin (Dept. of Korean OB & GY, School of Korean Medicine, Dong-Shin University) ;
  • Gim, Bo-Ri (Dept. of Korean OB & GY, School of Korean Medicine, Dong-Shin University) ;
  • Cho, Seong-Hee (Dept. of Korean OB & GY, School of Korean Medicine, Dong-Shin University) ;
  • Yang, Seung-Jeong (Dept. of Korean OB & GY, School of Korean Medicine, Dong-Shin University)
  • 투고 : 2020.01.07
  • 심사 : 2020.05.29
  • 발행 : 2020.05.29
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: This study was conducted to find out research trends for uterine leiomyoma and to recognize the efficacy and safety of herbal medicine treatment for uterine leiomyoma and to help in the clinical research of herbal medicine treatment for uterine leiomyoma in the future. Methods: Based on eight domestic and foreign databases, We analyzed the Randomized Controlled Trials using herbal medicine for uterine leiomyoma. Data retrieval was carried out on September 10, 2019 and the latest five-year papers were included. The treatment group was treated with herbal medicine and the control group was treated with western medicine. Results: 473 studies were searched in domestic and foreign databases, and 12 studies were finally selected. Although the indicators varied, all studies used total efficiency rate as indicators. In all 12 studies, the treatment group treated with herbal medicine was more effective than the control group treated with Western medicine.

키워드

참고문헌

  1. Park SY, Jung H. Fatal Pulmonary Thromboembolism After Uterine Artery Embolization For Uterine Myoma : A Case Report. Korean J Obstet Gynecol. 2011;54(1):62-5. https://doi.org/10.5468/KJOG.2011.54.1.62
  2. Kang SY, et al. A Case of Hemoperitoneum from a Spontaneous Venous Rupture Overlying Uterine Leiomyoma. Korean J Obstet Gynecol. 2012;55(7):526-9. https://doi.org/10.5468/KJOG.2012.55.7.526
  3. The Society of Korean Medicine Obstetrics and Gynecology. ORIENTAL OBSTETRICS & GYNECOLOGY(2nd volume). 1st rev. ed. Seoul:Euiseongdang. 2012:320-9.
  4. Cramer DW. Epidemiology of myomas. Semin Reprod Endocrinol. 1992;10(4):320-4. https://doi.org/10.1055/s-2007-1018889
  5. Parazzini F, et al. Reproductive factors and risk of uterine fibroids. Epidemiology. 1996;7(4):440-2. https://doi.org/10.1097/00001648-199607000-00018
  6. Rein MS. Advances in uterine leiomyoma research: the progesterone hypothesis. Environmental Health Perspectives. 2000;108:791-3. https://doi.org/10.1289/ehp.00108s5791
  7. Korean Society of Obstetrics and Gynecology. Gynecology. 5th rev. ed. Seoul:Korea Medical Book Publishing Company. 2015:107-15.
  8. Park CG, at al. The effect of Sparganii Rhizoma on the proliferation inhibition of human uterine leiomyoma cell and expression of gene related cell apoptosis. The Journal of Oriental Obstetrics & Gynecology. 2006;19(2):199-213.
  9. Kim SJ, at al. Induced apoptosis in human Uterine Leiomyoma Cell by treatment with Chiljehyangbu-hwan. The Journal of Oriental Obstetrics & Gynecology. 2007;20(2):25-42.
  10. Jung MJ, Ryu HC. 3 Case Reports of Uterine Fibroid treated by Herbal medicine based on Shanghanlun provisions. Korean Medical Association of Clinical Sanghan Geumgwe. 2015;7(1):29-43.
  11. Lee JI, at al. A Case Report of One Patient with Infertility Accompanied by Adenomyosis and Uterine Myoma. The Journal of Oriental Obstetrics & Gynecology. 2015;28(1):158-66. https://doi.org/10.15204/jkobgy.2015.28.1.158
  12. Kim DI. A Study of the Guidelines for Investigation and Management of Uterine Myomas with Korean Medicine Therapies in Korea. The Journal of Oriental Obstetrics & Gynecology. 2016;19(2):240-60.
  13. The national college of Korean medicine herbology textbook compilation committee. Herbology. 2nd rev. ed. Seoul:Younglimsa. 2012:10-8, 235-8, 345-7, 455-7, 462-3, 635-6.
  14. Hao S. Clinical analysis of treatment of uterine fibroids by activating blood circulation and removing blood stasis. Cardiovascular Disease Electronic Journal of integrated traditional Chinese and Western Medicine. 2019;7(17):169.
  15. LI D, et al. Clinical Effect of Nourishing Healthy Qi and Eliminating Blood Stasis Formula Lichong Decoction for Treating Hysteromyoma. Liaoning Journal of Traditional Chinese Medicine. 2018;45(8):1653-6.
  16. Jin J. Effect of Traditional Chinese Medicine Syndrome Differentiation on Multiple Uterine Fibroids and Its Effect on the Improvement of Symptoms and Signs. Smart Healthcare. 2018;4(27):68-9.
  17. Qiu F, Huang K. Efficacy and safety of Xuefu Zhuyu Decoction in the treatment of patients with uterine fibroids. Journal of Clinical Medical. 2018;5(31):169-70.
  18. Wang Z. A clinical analysis of treating hysteromyoma with the Xiaozheng decoction. Clinical Journal of Chinese Medicine. 2017;9(35):92-4.
  19. Niu Y. A Preliminary Study on Therapeutic Effect of Traditional Chinese Medicine in the Treatment of Uterine Fibroids. China Continuing Medical Education. 2016;8(21):166-7.
  20. Xu J, Yagn L, Nie W. Effect of Yiqihuayu herb on serum NF-${\kappa}B$ p65 and myocardin in patients with hysteromyoma. Chinese Journal of Biochemical Drugs. 2015;6(35):92-4.
  21. Chen L, Wu M, He H. Syndrome Differentiation of Traditional Chinese Medicine for the Treatment of Multiple Uterine Fibroids Observation. Journal of Liaoning University of TCM. 2015;17(4):177-9.
  22. Jiang L. Analysis of the influence of TCM syndrome differentiation therapy on prognosis of uterine fibroids. Global Traditional Chinese Medicine. 2015;8(S1):34.
  23. Wang C. Traditional Chinese Medicine Treatment Experience of Patients with Uterine Fibroids. China Health Standard Management. 2015;6(15):168-9.
  24. Zhang L, Ma W. Clinical observation on treating uterine fibroids with mifepristone and Xiaoyao San. Clinical Journal of Chinese Medicine. 2014;6(32):86-7.
  25. Gong J. Therapeutic effect of promoting blood circulation and removing blood stasis on uterine fibroids. Jounal of Practical Traditional Chinese Medicine. 2014;30(10):918-9.
  26. Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril. 1981;36(4):433-45. https://doi.org/10.1016/s0015-0282(16)45789-4
  27. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94(4):435-8. https://doi.org/10.1093/ajcp/94.4.435
  28. Mifepristone (Mifeprex). 2016 May 15. Available from:URL:https://medlineplus.gov/druginfo/meds/a600042.html
  29. Park YS, at al. A report on 2 cases of Uterine myoma. The Journal of Oriental Obstetrics & Gynecology. 2004;17(3):199-208.
  30. Wee HS, at al. Uterine Myoma 41 Case Series. The Journal of Oriental Obstetrics & Gynecology. 2006;19(1):272-85.